-transparent.png){kind=logo}
Suerpoxide dismutase was administered intravenously to rats 50 min prior to intravenous administration of a diabetogenic dose of streptozotocin. A dose of 45 mg/kg streptozotocin alone produced marked glucose intolerance and a decrease in pancreatic insulin content to less than 10% of control; both of these effects were abolished by prior administration of 105 mu/g of superoxide dismutase. Superoxide dismutase (105 mu/g) administered 50 min before 65 mg/kg intravenous streptozotocin did not prevent the development of diabetes. The fall in pancreatic insulin content seen with streptozotocin alone was, however, partially reversed by superoxide dismutase.
Related Publications
M J Robbins, and
R A Sharp, and
A E Slonim, and
I M Burr
November 1984,
Acta endocrinologica,
M J Robbins, and
R A Sharp, and
A E Slonim, and
I M Burr
August 1981,
Diabetes,
M J Robbins, and
R A Sharp, and
A E Slonim, and
I M Burr
October 1996,
British journal of pharmacology,
M J Robbins, and
R A Sharp, and
A E Slonim, and
I M Burr
December 1985,
Sheng li xue bao : [Acta physiologica Sinica],
M J Robbins, and
R A Sharp, and
A E Slonim, and
I M Burr
January 1978,
Photochemistry and photobiology,
M J Robbins, and
R A Sharp, and
A E Slonim, and
I M Burr
November 1973,
Biochemical and biophysical research communications,
M J Robbins, and
R A Sharp, and
A E Slonim, and
I M Burr
January 1988,
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
M J Robbins, and
R A Sharp, and
A E Slonim, and
I M Burr
August 2001,
Kidney international,
M J Robbins, and
R A Sharp, and
A E Slonim, and
I M Burr
January 2011,
Experimental diabetes research,
M J Robbins, and
R A Sharp, and
A E Slonim, and
I M Burr
August 1997,
The American journal of physiology,
